mRNA |
QL-VIII-58 |
GDSC1000 |
pan-cancer |
AAC |
-0.078 |
0.09 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.09 |
mRNA |
HG-5-113-01 |
GDSC1000 |
pan-cancer |
AAC |
0.077 |
0.09 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.09 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.09 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.09 |
mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.09 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.09 |
mRNA |
QL-XII-47 |
GDSC1000 |
pan-cancer |
AAC |
-0.054 |
0.09 |
mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.09 |